BG-89894

· BeOne Medicines

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BG-89894, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors [Phase 1]